William R Ringo is Director of FIVE PRIME THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of FPRX, which is worth approximately $0. The most recent transaction as insider was on Apr 05, 2021, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

WILLIAM R RINGO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 05 2021
SELL
Bona fide gift
-
10,000 Reduced 100.0%
0 Common Stock
Nov 11 2020
SELL
Open market or private sale
$1,776,578 $22.5 p/Share
78,959 Reduced 88.76%
10,000 Common Stock
Nov 11 2020
BUY
Exercise of conversion of derivative security
$198,187 $2.51 p/Share
78,959 Added 68.68%
36,000 Common Stock

Also insider at

ASMB
ASSEMBLY BIOSCIENCES, INC. Healthcare
SNSE
Sensei Biotherapeutics, Inc. Healthcare
WRR

William R Ringo

Director
South San Francisco, CA

Track Institutional and Insider Activities on FPRX

Follow FIVE PRIME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FPRX shares.

Notify only if

Insider Trading

Get notified when an Five Prime Therapeutics, Inc. insider buys or sells FPRX shares.

Notify only if

News

Receive news related to FIVE PRIME THERAPEUTICS, INC.

Track Activities on FPRX